• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » HighQ partners with SAFE-BioPharma

HighQ partners with SAFE-BioPharma

December 7, 2011
CenterWatch Staff

London-based HighQ has formed a vendor partnership with the SAFE-BioPharma Association. Companies within the global pharmaceutical and biotechnology industry use the SAFE-BioPharma standard in FDA Title 21 CFR part 11 compliant processes for signing SOPs, quality and compliance documentation, research and development documentation, corporate compliance documents and more.

HighQ provides the life sciences industry with a unified space for secure document exchange and social collaboration across a global network of employees, researchers and partners – both internal and external to the company. HighQ Collaborate, a secure cloud-based platform, allows users to disseminate information to discovery teams, CROs, investigators and business development partners worldwide. Users will have the opportunity to securely exchange documents using their SAFE-BioPharma digital identities on the HighQ Collaborate platform, ensuring their credentials are available anytime and anywhere.

"By making use of collaborative tools such as wiki pages and blog posts alongside traditional office software (Word, Excel, PowerPoint, PDF etc.), sponsors, CROs and investigators can work more efficiently, eliminating the time consuming need to print out physical documents that require signatures during clinical trials. By partnering with the SAFE-BioPharma Association, HighQ will enable the life sciences industry to have an efficient, enforceable and regulatory-compliant document approval process, whilst facilitating secure document exchange and social collaboration throughout the organization," said Jacob Mathew, consultant – KM Practice, HighQ.

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing